Trial Profile
A Phase III Study of the Safety and Efficacy of Ferumoxytol (Compared With Oral Iron) as an Iron Replacement Therapy in Hemodialysis Patients Who Are Receiving Supplemental EPO Therapy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Apr 2022
Price :
$35
*
At a glance
- Drugs Ferumoxytol (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- Sponsors AMAG Pharmaceuticals
- 15 Sep 2014 New trial record